Viseon logo

Viseon Funding & Investors

Viseon is a privately held medical device company committed to developing proprietary technology for use in Minimally Invasive Spine Surgery (MISS) procedures. Viseon has progressed rapidly over the past 6-months, having developed a unique array of devices to improve the procedural and clinical outcomes of many minimally invasive spine surgery procedures. In addition to rapid product development of its initial products, Viseon has assembled a world-class Scientific Advisory Board of leading MISS physicians, amassed 13 patents to solidify its intellectual property platform, and completed a series of pre-clinical studies supporting initial human-use, scheduled to begin soon. Viseon was founded in early 2017 as a spin-out from Rebound Therapeutics Corporation.

viseon-spine.com

Total Amount Raised: $27,200,000

Viseon Funding Rounds

  • Series B

    $18,000,000

    Series B Investors

    Invus
    HBM-MedFocus
    Wexford Capital
  • Series A

    $5,000,000

    Series A Investors

    Invus
    HBM-MedFocus
    Wexford Capital
  • Post Ipo Equity

    $4,200,000

Funding info provided by Diffbot.